(Q37474101)

20 August 2017

title

Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver? (English)

1 reference

20 August 2017

0 references

1 reference

2

Frank Buntinx

1 reference

20 August 2017

Birgitte Schoenmakers

series ordinal

1

object named as

Birgitte Schoenmakers

1 reference

20 August 2017

3

Jan De Lepeleire

1 reference

20 August 2017

language of work or name

English

0 references

publication date

7 May 2009

1 reference

20 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Family Practice

1 reference

20 August 2017

volume

26

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

279-286

1 reference

Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Caregiver well-being: a multidimensional examination of family caregivers of demented adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Associations of caregiver stressors and uplifts with subjective well-being and depressive mood: a meta-analytic comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Insulin-like growth factor binding proteins: new proteins, new functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Patient and caregiver characteristics associated with depression in caregivers of patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Review Article: Management of Behavioral Symptoms in Progressive Degenerative Dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Long-term care placement of dementia patients and caregiver health and well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Predictors of institutionalization among caregivers of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Family carers' responses to behavioural and psychological symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Alzheimer's disease: current pharmacotherapy in the context of patient and family needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Drug treatment of Alzheimer's disease. Effects on caregiver burden and patient quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Assessment, measures and approaches to easing caregiver burden in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Medical management of advanced dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Caregiver-specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Defining the role of the caregiver in Alzheimer's disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Impact of donepezil treatment for Alzheimer's disease on caregiver time

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

The effects of galantamine treatment on caregiver time in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Caregiving and the stress process: an overview of concepts and their measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

The screen for caregiver burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Relatives of the impaired elderly: correlates of feelings of burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Economic impact of introducing propentofylline for the treatment of dementia in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Reducing the burden of caring for Alzheimer's disease through the amelioration of "delusions of theft" by drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Dementia caregiver intervention research: in search of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Meta-analysis of psychosocial interventions for caregivers of people with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

Are All Caregivers Created Equal? Stress in Caregivers to Adults With and Without Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP024

21 January 2018

Identifiers

DOI

10.1093/FAMPRA/CMP024

1 reference

20 August 2017

1 reference